RxDoctor Payments Data

Robert Suares, MD

Family Medicine · Greenville, MSNPI 1275733636

Payments from drug & device makers

$1,501in general payments, 2019–2025

Across 101 payments — averaging $14.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$311
  • Novartis$214
  • Pfizer$205
  • AbbVie$149
  • Boehringer Ingelheim$103
  • Lilly USA, LLC$71
  • plus $450 from 14 others

What the payments were for

  • Food & beverage$1,48799%
  • Education$151%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,501 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$281,405
Medicare patients
700
Services billed
7,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide188$206,501
JanuviaSitagliptin Phosphate118$122,400
EliquisApixaban126$108,751
JardianceEmpagliflozin89$103,035
FarxigaDapagliflozin Propanediol104$97,688
RybelsusSemaglutide34$55,320
MounjaroTirzepatide51$51,585
Tresiba Flextouch U-100Insulin Degludec58$48,997
XareltoRivaroxaban60$43,336
LinzessLinaclotide53$39,303
EntrestoSacubitril/Valsartan56$36,025
Breztri AerosphereBudesonide/Glycopyr/Formoterol38$28,069
Tresiba Flextouch U-200Insulin Degludec19$19,108
TrulicityDulaglutide12$17,079
CreonLipase/Protease/Amylase12$13,950

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$16$261,821222 claims
AstraZenecaFarxiga, Breztri Aerosphere, Brilinta, Symbicort$311$152,060201 claims
MerckJanuvia$56$122,400118 claims
PfizerEliquis$205$108,751126 claims
Boehringer IngelheimJardiance$103$103,03589 claims
Lilly USA, LLCMounjaro, Trulicity$71$68,66463 claims
AbbVieLinzess, Creon, Lumigan$149$58,50978 claims
Johnson & JohnsonXarelto$30$43,33660 claims
NovartisEntresto$214$36,02556 claims
GSKBreo Ellipta, Shingrix$15$11,58529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Greenville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →